期刊文献+

慢性阻塞性肺疾病中Sirtuins的研究进展 被引量:6

Recent advances of Sirtuins in chronic obstructive pulmonary disease
下载PDF
导出
摘要 Sirtuins是第Ⅲ类组蛋白去乙酰化酶,主要成员SIRT1、SIRT6与慢性阻塞性肺疾病(COPD)发病机制有密切关系。SIRT1、SIRT6在COPD患者肺部中表达下调,并通过多种机制调节炎性反应、肺部自噬与衰老。Sirtuins可能是COPD发生过程中的一个调控分子家族。 Sirtuins are class Ⅲ histone deacetylase.SIRT1 and SIRT6 are the major members of Sirtuins participated in the development of chronic obstructive pulmonary disease(COPD).The expression of SIRT1 and SIRT6 was down-regulated in the lungs of patients with COPD.They regulate inflammatory reaction,lung autophagy and senescence through multiple mechanisms.Sirtuins may be one of major regulatory molecule family in the progression of COPD.
作者 陈刚
出处 《基础医学与临床》 CSCD 北大核心 2014年第7期1010-1013,共4页 Basic and Clinical Medicine
关键词 慢性阻塞性肺病 SIRTUINS SIRT1 SIRT6 COPD Sirtuins SIRT1 SIRT6
  • 相关文献

参考文献25

  • 1Vestbo J,Hurd SS,Agusti AG,et al.Global strategy for the diagnosis,management,and prevention of chronic obstructive pulmonary disease:GOLD executive summary[J].Am J Respir Crit Care Med,2013,187:347-365.
  • 2Corbi G,Bianco A,Turchiarelli V,et al.Potential mechanisms linking atherosclerosis and increased cardiovascular risk in COPD:focus on sirtuins[J].Int J Mol Sci,2013,14:12696-12713.
  • 3Mahajan SS,Leko V,Simon JA,et al.Sirtuin modulators[J].Handb Exp Pharmacol,2011,206:241-255.
  • 4Haigis MC,Sinclair DA.Mammalian sirtuins:biological insights and disease relevance[J].Annu Rev Pathol,2010,5:253-295.
  • 5Beauharnois JM,Bolivar BE,Welch JT.Sirtuin 6:a review of biological effects and potential therapeutic properties[J].Mol Biosyst,2013,9:1789-1806.
  • 6Caito S,Hwang JW,Chung S,et al.PARP-1 inhibition does not restore oxidant-mediated reduction in SIRT1 activity[J].Biochem Biophys Res Commun,2010,392:264-270.
  • 7Hwang JW,Chung S,Sundar IK,et al.Cigarette smokeinduced autophagy is regulated by SIRT1-PARP-1-dependent mechanism:implication in pathogenesis of COPD[J].Arch Biochem Biophys,2010,500:203-209.
  • 8Rajendrasozhan S,Yang SR,Kinnula VL,et al.SIRT1,an antiinflammatory and antiaging protein,is decreased in lungs of patients with chronic obstructive pulmonary disease[J].Am J Respir Crit Care Med,2008,177:861-870.
  • 9Sundar IK,Yao H,Rahman I.Oxidative stress and chromatin remodeling in chronic obstructive pulmonary disease and smoking-related diseases[J].Antioxid Redox Signal,2013,18:1956-1971.
  • 10Yang SR,Wright J,Bauter M,et al.Sirtuin regulates cigarette smoke-induced proinflammatory mediator release via RelA/p65 NF-kappaB in macrophages in vitro and in rat lungs in vivo:implications for chronic inflammation and aging[J].Am J Physiol Lung Cell Mol Physiol,2007,292:567-576.

同被引文献65

  • 1肖建,杜春玲.慢性阻塞性肺疾病病因及发病机制研究进展[J].中国老年学杂志,2014,34(11):3191-3194. 被引量:165
  • 2宋爱玲,兰智新,王慧.低分子肝素治疗慢性阻塞性肺病急性发作期的临床研究(附30例报告)[J].中国医药导刊,2013,15(S1):151-153. 被引量:2
  • 3赵蜀军,蔡圣荣,方志斌,刘涌,王元勋.慢性支气管炎肺气虚证大鼠血清IL-8、MDA、SOD变化特征[J].安徽中医学院学报,2005,24(2):21-23. 被引量:10
  • 4Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstruc- tive pulmonary disease:GOLD executive summary[ J]. AM J Respir Crit Care Med,2013 ,187 :347-365.
  • 5Richard KA, John C, William CB, et al. Azithromycin for prevention of exacerbations of COPD[ J]. New Engl J Med, 2011,365 : 689- 698.
  • 6Steven S, Gert L, Marc D. Preventing COPD exacerbations with macrolides: a review and budget impact analysis [ J ]. Respir Med, 2013,107:637-648.
  • 7Wong C, Jayaram L, Karalus N, et al. Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiec- tasis(EMBRACE) : a randomised, double-blind, placebo- control trial J]. Lancet,2012,380:660-667.
  • 8Patricia CV, Peter SM, Catherine AB, et al. Long-term az- ithromycin for indigenous children with non-cystic-fibrosis bronchiectasis or chronic suppurative lung disease (Bron- chieetasis Intervention Study) :a muhicentre, double-blind, randomised controlled trial [ J ]. Lancet Respir Med, 2013, 1 : 610-620.
  • 9Catherine H, Megan K, Joshua LK. Rhinovirus and asthma: a storied history of Incompatibility[ J ]. Curr Allergy Asthma Rep,2015,15 : 1-8.
  • 10Slater M, Rivett DW, Williams L, et al. The impact of az- ithromycin therapy on the airway microbiota in asthma [ J ]. Thorax, 2014,69 : 673- 674.

引证文献6

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部